|
IR Home | SEC Filings | Financial Reports | Company News | Request Information | Mgmt & Board | Code of Ethics | Webcast | Newsletter
Lannett Company, Inc. develops, manufactures, packages, markets and distributes pharmaceutical products sold under generic chemical names. In addition, we provide label pharmaceutical products for other companies. Lannett Company, Inc. manufactures only solid oral dosage forms, including tablets and capsules, but it is pursuing partnerships and research contracts for the development and production of other dosage forms, including liquids and injectable products. For a complete listing of our products, please visit our products page. The financial success that Lannett has been experiencing can be attributed to our unique position in this economy. We are now in a growth trend as is the generic industry. That, combined with the dramatic growth in the population base that uses generic drugs, has provided Lannett with tremendous growth opportunities. Company News11/13/08 - Lannett Company Reports Strong Fiscal 2009 First-Quarter Financial Results...more 11/11/08 - Lannett Company Report Fiscal 2009 First-Quarter Financial Results And Host Conference Call On Thursday November 13, 2008...more 10/08/08 - Lannett Company Receives Patent Approval For Method Of Manufacturing Certain Morphine Derivatives...more 10/06/08 - Lannett Company Announces Positive Results Of Facilities Inspection...more 09/29/08 - Lannett Company Reports Fiscal 2008 Fourth Quarter, Full-Year Financial Results...more |
